Stockreport

Crinetics Pharmaceuticals Says First Patient Dosed in Phase 3 Trial of Atumelnant for Classic CAH [Yahoo! Finance]

Crinetics Pharmaceuticals, Inc.  (CRNX) 
Last crinetics pharmaceuticals, inc. earnings: 3/9 04:10 pm Check Earnings Report
PDF Crinetics Pharmaceuticals (CRNX) said late Thursday it has dosed the first patient in a Phase 3 clin [Read more]